BofA raised the firm’s price target on Stevanato Group (STVN) to $26 from $24 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and ...

Top performing mid-cap stocks in the last week, including Semtech, Stevanato, Ambarella, Ardent Health, BILL, Box, and Grupo Financiero Galicia.

Morgan Stanley analyst Tejas Savant maintained a Hold rating on Stevanato Group (STVN – Research Report) today and set a price target of $23.00. The company’s shares closed last Friday at $22.94.